These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1700585)

  • 41. Long-term outcome for lymph node-positive prostate cancer.
    Swanson GP; Riggs MW; Herman M
    Prostate Cancer Prostatic Dis; 2008; 11(2):198-202. PubMed ID: 17519924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.
    Nakamachi H; Suzuki H; Akakura K; Imamoto T; Ueda T; Ishihara M; Furuya Y; Ichikawa T; Igarashi T; Ito H
    Prostate Cancer Prostatic Dis; 2002; 5(2):159-63. PubMed ID: 12497007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer.
    Homma Y; Akaza H; Okada K; Yokoyama M; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
    Int J Urol; 2004 Apr; 11(4):218-24. PubMed ID: 15028100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical study on adenocarcinoma of the prostate].
    Mikata N; Imao S; Komatsu H
    Hinyokika Kiyo; 1993 Oct; 39(10):913-7. PubMed ID: 8266854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
    Granfors T; Modig H; Damber JE; Tomic R
    J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate.
    Oefelein MG; Smith ND; Grayhack JT; Schaeffer AJ; McVary KT
    J Urol; 1997 Oct; 158(4):1460-5. PubMed ID: 9302143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Induction therapy with CDDP and ADM for stage D prostatic cancer and its clinical response].
    Yushita Y; Sakai H; Nomata K; Suzu H; Minami Y; Ogawa S; Yamashita S; Kanetake H; Saito Y
    Hinyokika Kiyo; 1990 Dec; 36(12):1415-21. PubMed ID: 2075879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostatic cancer in patients 80 years of age.
    Pow-Sang J; Ramirez G; Benavente V; Pow-Sang ; Garrido G
    Prog Clin Biol Res; 1987; 243B():321-7. PubMed ID: 3659028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chemo-endocrine therapy for newly diagnosed stage D2 prostate cancer].
    Saito T; Kitamura Y; Komatsubara S
    Hinyokika Kiyo; 2005 Dec; 51(12):789-92. PubMed ID: 16440724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
    Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical study of endocrine therapy in stage B and C prostate cancer].
    Uei T; Okazaki H; Nakamura T; Katou N; Suzuki K; Yamanaka H
    Hinyokika Kiyo; 2003 Nov; 49(11):639-43. PubMed ID: 14719450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):275-84. PubMed ID: 2191569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical study of total prostatectomy for prostatic cancer].
    Fujii A; Gohji K; Morisue K; Maruyama S; Kizaki T; Oka N
    Hinyokika Kiyo; 1994 Feb; 40(2):111-7. PubMed ID: 8128919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Endocrine therapy of stage D2 prostatic carcinoma].
    Akimoto S; Akakura K; Fuse H; Shimazaki J; Yatani R
    Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):1-10. PubMed ID: 2456417
    [No Abstract]   [Full Text] [Related]  

  • 56. [Can the hormone-resistance of cancer of the prostate be predicted from the initial biopsy?].
    Bittard H; Carbillet JP; Jeldi A; Khenifar E; Shikfa M; Wenzel H; Bretillot F; Bittard M
    Ann Urol (Paris); 1990; 24(4):340-4. PubMed ID: 1699470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical and pathological study of 152 cases of prostatic cancer].
    Kondoh I; Miura T; Shimura H; Harada M; Fujii H
    Hinyokika Kiyo; 1992 Jun; 38(6):671-6. PubMed ID: 1632321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prognostic factors in patients with advanced prostatic cancer (stage D2) initially treated with endocrine therapy].
    Matsuda H; Shinohara N; Nonomura K; Nohnaka O; Demura T; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):688-94. PubMed ID: 8709446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of newly diagnosed stage D2 prostatic carcinoma with hormonal therapy alone, or chemotherapy agents in combination with hormones].
    Fujii A; Oka N; Miyasaki S; Higuchi A; Tomioka O; Morishita S; Yamanaka K; Itoh N; Okamoto Y; Tanaka H
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1656-63. PubMed ID: 1722834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis of clinically undiagnosed prostatic carcinoma and the influence of endocrine therapy.
    Heaney JA; Chang HC; Daly JJ; Prout GR
    J Urol; 1977 Aug; 118(2):283-7. PubMed ID: 894807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.